JEFFREY YOCUM: Open Payments
NPI 1720032493 · LEBANON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,761 in 115 payments from 29 companies in 2025. Trend: 2023 $1,470 · 2024 $1,279 · 2025 $1,761
Food & beverage: $1,718Education: $43
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 15 | $241 |
| ABBVIE INC. | 18 | $214 |
| Novo Nordisk Inc | 9 | $171 |
| PFIZER INC. | 13 | $162 |
| Supernus Pharmaceuticals, Inc. | 9 | $102 |
| Exact Sciences Corporation | 6 | $102 |
| Sumitomo Pharma America, Inc. | 2 | $63 |
| Verona Pharma, Inc. | 2 | $54 |
| MDD US Operations, LLC | 9 | $50 |
| Phathom Pharmaceuticals, Inc. | 3 | $48 |
Products named: MOUNJARO, QULIPTA, JARDIANCE, ELIQUIS, Ozempic, Qelbree, Cologuard Collection Kit, UBRELVY.
Industry payments across PA — which companies pay providers there.
